Blood test boosts colon cancer screening in those who skipped stool tests
NCT ID NCT05987709
First seen Jan 11, 2026 · Last updated May 25, 2026 · Updated 19 times
Summary
This study tested whether offering a simple blood test (Guardant SHIELD) helps more people complete colorectal cancer screening compared to usual care. About 2,000 adults aged 45-75 who had not returned their stool test took part. The main goal was to see how many got screened within 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kaiser Permanente Northwest
Portland, Oregon, 97227, United States
Conditions
Explore the condition pages connected to this study.